A detailed history of Comerica Bank transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Comerica Bank holds 270 shares of PTGX stock, worth $12,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
270
Previous 270 -0.0%
Holding current value
$12,376
Previous $7,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$21.79 - $32.15 $936 - $1,382
43 Added 18.94%
270 $7,000
Q4 2023

Feb 14, 2024

BUY
$14.05 - $23.44 $3,189 - $5,320
227 New
227 $5,000

Others Institutions Holding PTGX

About Protagonist Therapeutics, Inc


  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.25B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.